Kwang-Yu Chang

9PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 22, 2026
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study.

|Jul 24, 2025
Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer.

Yung-Chieh Chang, Szu-Jung Chen, Shang-Hung Chen

|Dec 02, 2024
Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression.

Caren Yu-Ju Wu, Yiyun Chen, Ya-Jui Lin

|Jul 13, 2022
SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma.

Chia-Hung Chien, Wen-Bin Yang, Jian-Ying Chuang

|Oct 23, 2021
SOD2 Enhancement by Long-Term Inhibition of the PI3K Pathway Confers Multi-Drug Resistance and Enhanced Tumor-Initiating Features in Head and Neck Cancer.

Wei-Ting Hsueh, Shang-Hung Chen, Chia-Hung Chien

|Jul 22, 2021
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers.

Kwang-Yu Chang, Nai-Jung Chiang, Shang-Yin Wu

Pageof 2

Frequent Collaborators

1 joint publications

Caren Yu-Ju Wu

1 joint publications

Yiyun Chen

1 joint publications

Ya-Jui Lin

1 joint publications

Kuo-Chen Wei